Abstract
The occurrence of acute kidney injury (AKI) is often the final step of a process that (1) failed in preventing significant kidney hits in highly susceptible patients, or (2) failed in preventing the progression of a subclinical AKI when a relatively minor kidney insult has still occurred. AKI diagnosis and timely identification is the mainstay of its therapeutic approach. This is particularly true in patients with numerous clinical risk factors, but also in those with apparently lower kidney susceptibility (in case they were in an unacknowledged state of subclinical AKI). The following paragraphs will describe the utility of biomarkers and the importance of a standardized AKI definition to help clinicians in accurately identifying the renal status of their patients.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
